Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Auditor change
Director departure
Appointed director
|
|
LifeMD, Inc. (CVLB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
SC 13G
| Divisadero Street Capital Management, LP reports a 5.3% stake in LifeMD, Inc. |
| 08/23/2023 |
4
| Simon Roberto (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 08/10/2023 |
8-K
| Investor presentation |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
8-K
| Quarterly results |
| 07/14/2023 |
8-K
| Quarterly results |
| 07/13/2023 |
4
| Alvarez Nicholas P (Chief Acquisition Officer) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Disposed/sold 200,000 options to buy
@ $7.92, valued at
$1.6M
|
|
| 07/13/2023 |
4
| Benathen Marc David (CFO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 125,000 shares
@ $0
Disposed/sold 200,000 options to buy
@ $21.2, valued at
$4.2M
Exercised 25,000 restricted stock units
@ $0
Exercised 25,000 restricted stock units
@ $0 |
|
| 07/07/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/29/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 06/16/2023 |
4
| Yecies Eric Harold (General Counsel & CCO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Disposed/sold 200,000 options to buy
@ $7.55, valued at
$1.5M
|
|
| 06/16/2023 |
4
| BHATIA NAVEEN (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 225,000 shares
@ $0 |
|
| 06/15/2023 |
4
| Jindal Piyush (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 225,000 shares
@ $0 |
|
| 06/15/2023 |
4
| Roberts Brad Michael (COO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Disposed/sold 200,000 options to buy
@ $7.5, valued at
$1.5M
|
|
| 06/07/2023 |
4
| Velge Bertrand (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 10,383 shares
@ $2.1651, valued at
$22.5k
Bought 129,117 shares
@ $2.1794, valued at
$281.4k
|
|
| 05/31/2023 |
4/A
| Galluppi Stefan (Chief Innovation Officer) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 4,608 shares
@ $2.17, valued at
$10k
|
|
| 05/24/2023 |
4
| Schreiber Justin (CEO) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Bought 17,664 shares
@ $2.152, valued at
$38k
Bought 32,336 shares
@ $2.06, valued at
$66.6k
|
|
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/28/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/27/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/22/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"AVENUE VENTURE OPPORTUNITIES FUND, L.P., a Delaware limited partnership as administrative agent and collateral agent and as a lender LOAN AND SECURITY AGREEMENT Borrower, Lenders and Agent anticipate entering into one or more transactions pursuant to which each Lender agrees to make available to Borrower a loan facility governed by the terms and conditions set forth in this document and one or more Supplements executed by Borrower, Lenders and Agent which incorporate this document by reference. Each Supplement constitutes a supplement to and forms part of this document, and will be read and construed as one with this document, so that this document and the Supplement constitute a single agreement between the parties . Accordingly, the parties agree as follows: ARTICLE 1 - INTERPRETATION 1....",
"“Loan and Security Agreement”), by and among Borrower, Lenders and Agent. All capitalized terms used in this Supplement and not otherwise defined in this Supplement have the meanings ascribed to them in Article 11 of the Loan and Security Agreement, which is incorporated in its entirety into this Supplement. In the event of any inconsistency between the provisions of the Loan and Security Agreement and this Supplement, this Supplement is controlling.",
"EXHIBIT A",
"PROMISSORY NOTE",
"LifeMD, Inc. Announces Closing of New $40 Million Credit Facility" |
|
| 03/22/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/10/2023 |
8-K
| Quarterly results |
| 02/06/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| FRIEDEMAN JESSICA (Chief Marketing Officer) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 150,000 shares
@ $0 |
|
| 01/05/2023 |
3
| FRIEDEMAN JESSICA (Chief Marketing Officer) has filed a Form 3 on LifeMD, Inc. |
| 12/23/2022 |
4
| Walsh Kathleen E (Director) has filed a Form 4 on LifeMD, Inc.|
Txns:
| Granted 75,000 shares
@ $0
Granted 37,500 options to buy
@ $2.3, valued at
$86.3k
|
|
| 12/23/2022 |
3
| Walsh Kathleen E (Director) has filed a Form 3 on LifeMD, Inc. |
| 12/21/2022 |
8-K
| Quarterly results |
|
|
|